Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/107377
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Alves, Raquel | - |
dc.contributor.author | Gonçalves, Ana Cristina | - |
dc.contributor.author | Jorge, Joana | - |
dc.contributor.author | Marques, Gilberto João Padilha | - |
dc.contributor.author | Luís, Dino | - |
dc.contributor.author | Ribeiro, André B. | - |
dc.contributor.author | Tavares, Paulo | - |
dc.contributor.author | Oliveiros, Bárbara | - |
dc.contributor.author | Almeida, António M. | - |
dc.contributor.author | Ribeiro, Ana Bela Sarmento | - |
dc.date.accessioned | 2023-07-06T11:07:14Z | - |
dc.date.available | 2023-07-06T11:07:14Z | - |
dc.date.issued | 2019-07-04 | - |
dc.identifier.issn | 2045-2322 | pt |
dc.identifier.uri | https://hdl.handle.net/10316/107377 | - |
dc.description.abstract | microRNAs (miRs) dysregulation have emerged as a crucial step in tumorigenesis, being related with cancer development, progression and response to treatment. In chronic myeloid leukaemia (CML), the resistance to tyrosine kinase inhibitors (TKI) is responsible for treatment failure and could be linked to changes in miRs expression. This work aimed to correlate the expression levels of 3 miRs, miR-21, miR-26b and miR-451, with response to TKI treatment in CML patients. miR-451 levels at diagnosis were significantly higher in patients with optimal response after 6 and 12 months of therapy. Conversely, patients without optimal response had highest levels of miR-21. miR-21 and miR-451 appear to be good biomarkers of response, able to predict optimal TKI responders (p < 0.05). Using the combined profile of both miRs, we create a predictive model of optimal response after one year of treatment. This study highlights the role of miR-21 and miR-451 expression levels at diagnosis in predicting which patients achieve the optimal response. | pt |
dc.language.iso | eng | pt |
dc.publisher | Springer Nature | pt |
dc.relation | SFRH/ BD/51994/2012 | pt |
dc.relation | CIMAGO (Project 10/14), by Faculty of Medicine of the University of Coimbra and Santander Totta Bank with the grant (FMUC-BST-2016-214) | pt |
dc.relation | FCT/ MCTES/PIDDAC (CNC.IBILI. Centre Reference: UID/NEU/04539/2013) | pt |
dc.rights | openAccess | pt |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt |
dc.subject.mesh | Adult | pt |
dc.subject.mesh | Aged | pt |
dc.subject.mesh | Biomarkers, Tumor | pt |
dc.subject.mesh | Cell Transformation, Neoplastic | pt |
dc.subject.mesh | Disease Progression | pt |
dc.subject.mesh | Female | pt |
dc.subject.mesh | Follow-Up Studies | pt |
dc.subject.mesh | Gene Expression Regulation, Leukemic | pt |
dc.subject.mesh | Humans | pt |
dc.subject.mesh | Imatinib Mesylate | pt |
dc.subject.mesh | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | pt |
dc.subject.mesh | Male | pt |
dc.subject.mesh | MicroRNAs | pt |
dc.subject.mesh | Middle Aged | pt |
dc.subject.mesh | Prognosis | pt |
dc.subject.mesh | Protein Kinase Inhibitors | pt |
dc.subject.mesh | Survival Rate | pt |
dc.subject.mesh | Tumor Cells, Cultured | pt |
dc.subject.mesh | Drug Resistance, Neoplasm | pt |
dc.title | MicroRNA signature refine response prediction in CML | pt |
dc.type | article | - |
degois.publication.firstPage | 9666 | pt |
degois.publication.issue | 1 | pt |
degois.publication.title | Scientific Reports | pt |
dc.peerreviewed | yes | pt |
dc.identifier.doi | 10.1038/s41598-019-46132-9 | pt |
degois.publication.volume | 9 | pt |
dc.date.embargo | 2019-07-04 | * |
uc.date.periodoEmbargo | 0 | pt |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | open | - |
item.openairetype | article | - |
item.languageiso639-1 | en | - |
item.fulltext | Com Texto completo | - |
item.cerifentitytype | Publications | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.orcid | 0000-0003-2599-6433 | - |
crisitem.author.orcid | 0000-0003-1470-4802 | - |
crisitem.author.orcid | 0000-0001-7832-4134 | - |
crisitem.author.orcid | 0000-0001-7836-8161 | - |
crisitem.author.orcid | 0000-0002-4142-4841 | - |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais I&D ICBR - Artigos em Revistas Internacionais FMUC Medicina - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
MicroRNA-signature-refine-response-prediction-in-CMLScientific-Reports.pdf | 1.42 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
24
checked on Aug 19, 2024
WEB OF SCIENCETM
Citations
20
checked on Aug 2, 2024
Page view(s)
96
checked on Aug 27, 2024
Download(s)
41
checked on Aug 27, 2024
Google ScholarTM
Check
Altmetric
Altmetric
This item is licensed under a Creative Commons License